Product Information
DULOXETINE HCL DR 30 MG CAP is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.0782 per EA under NDC 47335038288. Its NADAC has been published 259 times since Mar 10, 2021.
FDA first approved this application on Dec 11, 2013.
The High Outlier badge above means this manufacturer's average price in the Duloxetine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
30 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
47335038288
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Effective Date
2/18/2026
Active Ingredients
DULOXETINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090745FDA Approved
12/11/2013
On Market Since
12/11/2013
Pharmacological Classes
Price Statistics
The NADAC for DULOXETINE HCL DR 30 MG CAP has been published 259 times since Mar 10, 2021, and over the history we have for it it has declined 30.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0782 per EA |
|---|---|
| All-time high | $0.1420 (Apr 14, 2021) |
| All-time low | $0.0696 (May 22, 2024) |
| 52-week high | $0.0794 |
| 52-week low | $0.0781 |
| Median price | $0.0988 |
| Average price | $0.0967 |
| Largest weekly change | +25.8% (Mar 17, 2021) |
| Weeks tracked | 259 |
| Tracking since | Mar 10, 2021 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-1.4%
3Y
-22.6%
5Y
-40.6%
All
-30.7%
Last surveyed Feb 18, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DULOXETINE HCL DR 30 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DULOXETINE HCL DR 30 MG CAP, manufactured by Sun Pharmaceutical Industries Inc., is $0.0782 per EA (NDC 47335038288), effective Feb 18, 2026.
How has the price of DULOXETINE HCL DR 30 MG CAP changed over time?
Over the history we have for it, the NADAC for DULOXETINE HCL DR 30 MG CAP has declined 30.7%. It has been tracked across 259 weekly CMS publications since Mar 10, 2021.
What are the highest and lowest recorded NADAC prices for DULOXETINE HCL DR 30 MG CAP?
Since Mar 10, 2021, the NADAC for DULOXETINE HCL DR 30 MG CAP has ranged from a low of $0.0696 (May 22, 2024) to a high of $0.1420 (Apr 14, 2021), with a median of $0.0988 per EA.
Are there cheaper alternatives to DULOXETINE HCL DR 30 MG CAP?
9 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DULOXETINE HCL DR 30 MG CAP in a comparable dosage form, but none are currently priced below it.
Who manufactures DULOXETINE HCL DR 30 MG CAP?
DULOXETINE HCL DR 30 MG CAP (NDC 47335038288) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.